Related content

An observational study of health-related quality of life and pain outcomes in chronic low back pain patients treated with fentanyl transdermal system

By Kosinski Mark R.   Schein Jeff R.   Vallow Sue M.   Ascher Steven   Harte Clare   Shikiar Richard   Frank Lori   Margolis Mary Kay   Vorsanger Gary  

Current Medical Research and Opinion, Vol. 21, Iss. 6, 2005-06 ,pp. : 849-862

Informa Healthcare

Access to resources Recommend Favorite

Benefits of transdermal fentanyl in patients with rheumatoid arthritis or with osteoarthritis of the knee or hip: an open-label study to assess pain control

By Pavelka Karel   Le Loet Xavier   Bjorneboe Olav   Herrero-Beaumont Gabriel   Richarz Ute  

Current Medical Research and Opinion, Vol. 20, Iss. 12, 2004-12 ,pp. : 1967-1977

Informa Healthcare

Access to resources Recommend Favorite

Costs of opioid therapy for chronic nonmalignant pain in Germany: an economic model comparing transdermal fentanyl (Durogesic) with controlled-release morphine

By Radbruch Lukas   Lehmann K.   Gockel H.-H.   Neighbors D.   Nuyts G.  

The European Journal of Health Economics, Vol. 3, Iss. 2, 2002-06 ,pp. : 111-119

Springer Publishing Company

Access to resources Recommend Favorite

Low doses of transdermal fentanyl in opioid-naive patients with cancer pain

By Mercadante Sebastiano   Porzio Gianpiero   Ferrera Patrizia   Aielli Federica   Adile Claudio   Ficorella Corrado  

Current Medical Research and Opinion, Vol. 26, Iss. 12, 2010-12 ,pp. : 2765-2768

Informa Healthcare

Access to resources Recommend Favorite

The QTc Effect of Low‐Dose Methadone for Chronic Pain: A Prospective Pilot Study

By  

PAIN MEDICINE, Vol. 16, Iss. 6, 2015-06 ,pp. : 1112-1121

John Wiley & Sons Inc

Access to resources Recommend Favorite